Catalin Buhimschi Md New Haven, CT - 06510

Catalin Buhimschi Md is categorized under Research and Development Laboratories in New Haven, CT and active since 2008.

Catalin Buhimschi Md was established in 2008, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Catalin Bumhischi at the company’s single location by writing to 333 Cedar St Room 804, New Haven, Connecticut CT 06510 or by phoning (203) 785-4536. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Catalin Buhimschi Md
Contact Person: Catalin Bumhischi
Address: 333 Cedar St Room 804, New Haven, Connecticut 06510
Phone Number: (203) 785-4536
Annual Revenue (USD): $50.000 to $99.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Catalin Buhimschi Md was started in 2008 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Catalin Bumhischi for inquiries that concern Catalin Buhimschi Md by calling the company number (203) 785-4536, as your correspondence is most welcome. Additionally, the physical location of the single location of Catalin Buhimschi Md can be found at the coordinates 41.302025,-72.933393 as well as the street address 333 Cedar St Room 804 in New Haven, Connecticut 06510.

For its online presence, you may visit Catalin Buhimschi Md’s website at and engage with its social media outlets through on Twitter and on Facebook.